Clinical Trials
Braintumor Website

There are 75 trials:
Facility: Massachusetts General Hospital
Displaying 1 - 50
[1 - 50]     [51 - 75]    
NCT Trial Name# of Centers

NCT01648348

  Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
242

NCT00991029

  Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
210

NCT00085735

  Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
184

NCT02388165

  Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation
179

NCT01231906

  Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
171

NCT01351545

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
133

NCT02667587

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
120

NCT01176565

  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
98

NCT02637856

  A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
84

NCT02796261

  Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
69

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
64

NCT01960075

  Established Status Epilepticus Treatment Trial
49

NCT02790632

  Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
46

NCT01955707

  Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
37

NCT02576431

  Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
36

NCT02320058

  An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
35

NCT01982942

  Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
28

NCT02709889

  Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
27

NCT02682927

  A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCL) in Children and Young Adults With Dravet Syndrome
23

NCT02997423

  Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
19

NCT02764151

  First in Patient Study for PF-06840003 in Malignant Gliomas
15

NCT02795780

  Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
13

NCT02450552

  Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
11

NCT01967810

  ANG1005 in Patients With Recurrent High-Grade Glioma
11

NCT02844439

  Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
10

NCT01790503

  A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
9

NCT02337491

  Pembrolizumab +/- Bevacizumab for Recurrent GBM
8

NCT02981940

  A Study of Abemaciclib in Recurrent Glioblastoma
7

NCT02586857

  A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)
7

NCT01339052

  Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
7

NCT02852655

  A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
6

NCT02977780

  INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
5

NCT01858168

  Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
5

NCT00859222

  LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
5

NCT01986348

  A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas
5

NCT00830531

  Pilot Study of Bumetanide for Newborn Seizures
4

NCT01112527

  PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
4

NCT01735188

  A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies
4

NCT02968940

  Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
3

NCT00916630

  Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
3

NCT01431378

  Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
3

NCT01054599

  Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
3

NCT01955395

  Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma
3

NCT03071874

  Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
3

NCT03139916

  Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
2

NCT01921335

  ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
2

NCT01466036

  Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
2

NCT02142803

  TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
2

NCT00821080

  Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
2

NCT01331291

  Bosutinib in Adult Patients With Recurrent Glioblastoma
2



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites